290 related articles for article (PubMed ID: 21383983)
1. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.
Lin AY; Chua MS; Choi YL; Yeh W; Kim YH; Azzi R; Adams GA; Sainani K; van de Rijn M; So SK; Pollack JR
PLoS One; 2011 Feb; 6(2):e16636. PubMed ID: 21383983
[TBL] [Abstract][Full Text] [Related]
2. Increased LEF1 expression and decreased Notch2 expression are strong predictors of poor outcomes in colorectal cancer patients.
Wang WJ; Yao Y; Jiang LL; Hu TH; Ma JQ; Ruan ZP; Tian T; Guo H; Wang SH; Nan KJ
Dis Markers; 2013; 35(5):395-405. PubMed ID: 24223455
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer.
Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J
J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H
Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Genetic Search to Clarify the Molecular Mechanism of Drug Resistance Identifies ASCL2-LEF1/TSPAN8 Axis in Colorectal Cancer.
Tanaka T; Kojima K; Yokota K; Tanaka Y; Ooizumi Y; Ishii S; Nishizawa N; Yokoi K; Ushiku H; Kikuchi M; Kojo K; Minatani N; Katoh H; Sato T; Nakamura T; Sawanobori M; Watanabe M; Yamashita K
Ann Surg Oncol; 2019 May; 26(5):1401-1411. PubMed ID: 30706227
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of Osteopontin (SPP1) in colorectal carcinoma requires a personalized molecular approach.
Assidi M; Gomaa W; Jafri M; Hanbazazh M; Al-Ahwal M; Pushparaj P; Al-Harbi A; Al-Qahtani M; Buhmeida A; Al-Maghrabi J
Tumour Biol; 2019 Sep; 41(9):1010428319863627. PubMed ID: 31500540
[TBL] [Abstract][Full Text] [Related]
7. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
8. Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer.
Snoeren N; Emmink BL; Koerkamp MJ; van Hooff SR; Goos JA; van Houdt WJ; de Wit M; Prins AM; Piersma SR; Pham TV; Belt EJ; Bril H; Stockmann HB; Meijer GA; van Hillegersberg R; Holstege FC; Jimenez CR; Fijneman RJ; Kranenburg OW; Rinkes IH
Br J Cancer; 2013 Sep; 109(6):1636-47. PubMed ID: 24002600
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.
Viana Lde S; Affonso RJ; Silva SR; Denadai MV; Matos D; Salinas de Souza C; Waisberg J
Oncology; 2013; 84(2):81-91. PubMed ID: 23128103
[TBL] [Abstract][Full Text] [Related]
11. Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells.
Uemura M; Yamamoto H; Takemasa I; Mimori K; Hemmi H; Mizushima T; Ikeda M; Sekimoto M; Matsuura N; Doki Y; Mori M
Clin Cancer Res; 2010 Sep; 16(18):4636-46. PubMed ID: 20823141
[TBL] [Abstract][Full Text] [Related]
12. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of TBL1XR1 in predicting liver metastasis for early stage colorectal cancer.
Liu H; Xu Y; Zhang Q; Yang H; Shi W; Liu Z; Li K; Gong Z; Ning S; Li S; Chen Y
Surg Oncol; 2017 Mar; 26(1):13-20. PubMed ID: 28317580
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of NDUFA4L2 is associated with poor prognosis in patients with colorectal cancer.
Lv Y; Nie SL; Zhou JM; Liu F; Hu YB; Jiang JR; Li N; Liu JS
ANZ J Surg; 2017 Dec; 87(12):E251-E255. PubMed ID: 27226356
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis.
Ye LC; Ren L; Qiu JJ; Zhu DX; Chen T; Chang WJ; Lv SX; Xu J
Tumour Biol; 2015 Nov; 36(11):8747-54. PubMed ID: 26050227
[TBL] [Abstract][Full Text] [Related]
16. High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma.
Gheytanchi E; Saeednejad Zanjani L; Ghods R; Abolhasani M; Shahin M; Vafaei S; Naseri M; Fattahi F; Madjd Z
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1631-1646. PubMed ID: 33616717
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of genes associated with poor prognosis of patients with colorectal cancer liver metastasis.
Qian Z; Zhang G; Song G; Shi J; Gong L; Mou Y; Han Y
Oncotarget; 2017 Apr; 8(15):25500-25512. PubMed ID: 28424419
[TBL] [Abstract][Full Text] [Related]
18. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
Wang L; Lin D; Fu Y; Lai M
Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
[TBL] [Abstract][Full Text] [Related]
19. An integrated study on TFs and miRNAs in colorectal cancer metastasis and evaluation of three co-regulated candidate genes as prognostic markers.
Eskandari E; Mahjoubi F; Motalebzadeh J
Gene; 2018 Dec; 679():150-159. PubMed ID: 30193961
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
